✦ LIBER ✦

Endothelin A Receptor Antagonists in Congestive Heart Failure: Blocking the Beast while Leaving the Beauty Untouched?

✍ Scribed by Lukas E. Spieker; Georg Noll; Frank T. Ruschitzka; Thomas F. Lu¨scher

Book ID: 110302686
Publisher: Springer
Year: 2001
Tongue: English
Weight: 338 KB
Volume: 6
Category: Article
ISSN: 1382-4147
DOI: 10.1023/a:1011456309039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endothelin receptor antagonists in conge

Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?

✍ Lukas E Spieker; Georg Noll; Frank T Ruschitzka; Thomas F Lüscher 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 673 KB

Comparison of the Effects of Selective E

Comparison of the Effects of Selective Endothelin ETa and ETb Receptor Antagonists in Congestive Heart Failure

✍ Atsuyuki Wada; Takayoshi Tsutamoto; Daisuke Fukai; Masato Ohnishi; Keiko Maeda; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 363 KB

A028 Increasing the expression of endoth

A028 Increasing the expression of endothelin converting enzyme and endothelin receptor subtypes in human myocardium with congestive heart failure

✍ H. Song; C. Wei 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

A Single-Center, Open-Label, Randomized,

A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study

✍ Nobuo Totsuka; Nobuhisa Awata; Katsuhito Takahashi; Hisako Yamamura; Junko Nakam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Long-term effects of darusentan on left-

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin-A Receptor Antagonist Trial in heart failure (EARTH): Randomised, double-blind, placebo-controlled trial

✍ I. Anand; J. McMurray; J.N. Cohn 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Coadministration of B-type natriuretic p

Coadministration of B-type natriuretic peptide and the vasopressin-2 receptor antagonist tolvaptan: a novel physiologic strategy to enhance water and sodium excretion without adversely affecting renal or neurohumoral function in experimental congestive heart failure

✍ Lisa C Costello-Boerrigter; Guido Boerrigter; Gail J Harty; John C Burnett 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 404 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.